Drug Search Results
More Filters [+]

SHR-1826

Alternative Names: SHR-1826, SHR 1826, SHR1826
Latest Update: 2024-02-20
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: N/A

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Suzhou Suncadia Biopharmaceuticals
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for SHR-1826

Countries in Clinic: China

Active Clinical Trial Count: 1

Highest Development Phases

Phase 1: Oncology Solid Tumor Unspecified

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

SHR-1826-I-101

P1

Recruiting

Oncology Solid Tumor Unspecified

2027-06-30

27%

Recent News Events

Date

Type

Title